200,000+ products from a single source!

sales@angenechem.com

Home > Quinoline > 174636-26-1

174636-26-1

174636-26-1 | 4-Quinolinecarboxamide, 3-hydroxy-2-phenyl-N-(1-phenylpropyl)-

CAS No: 174636-26-1 Catalog No: AG00BABR MDL No:MFCD00944075

Product Description

Catalog Number:
AG00BABR
Chemical Name:
4-Quinolinecarboxamide, 3-hydroxy-2-phenyl-N-(1-phenylpropyl)-
CAS Number:
174636-26-1
MDL Number:
MFCD00944075
IUPAC Name:
3-hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide
InChI:
InChI=1S/C25H22N2O2/c1-2-20(17-11-5-3-6-12-17)27-25(29)22-19-15-9-10-16-21(19)26-23(24(22)28)18-13-7-4-8-14-18/h3-16,20,28H,2H2,1H3,(H,27,29)/t20-/m0/s1
InChI Key:
BIAVGWDGIJKWRM-FQEVSTJZSA-N
UNII:
CZ3T9T146K

Properties

Complexity:
527  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0
Exact Mass:
382.168g/mol
Formal Charge:
0
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
382.463g/mol
Monoisotopic Mass:
382.168g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
62.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5.7  

Literature

Title Journal
Identification of a crucial amino acid in the helix position 6.51 of human tachykinin neurokinin 1 and 3 receptors contributing to the insurmountable mode of antagonism by dual NK₁/NK₃ antagonists. Journal of medicinal chemistry 20120614
Testicular toxicity induced by a triple neurokinin receptor antagonist in male dogs. Reproductive toxicology (Elmsford, N.Y.) 20110501
Bidirectional regulation of human colonic smooth muscle contractility by tachykinin NK(2) receptors. Journal of pharmacological sciences 20110101
Virtual screening to identify novel antagonists for the G protein-coupled NK3 receptor. Journal of medicinal chemistry 20101125
Bronchoconstrictor effect of the tachykinin NK₃-receptor agonists [MePhe⁷]-neurokinin B and senktide in the isolated guinea pig lung. Experimental lung research 20101101
Identification of a critical residue in the transmembrane domain 2 of tachykinin neurokinin 3 receptor affecting the dissociation kinetics and antagonism mode of osanetant (SR 142801) and piperidine-based structures. Journal of medicinal chemistry 20091126
New quinoline NK3 receptor antagonists with CNS activity. Bioorganic & medicinal chemistry letters 20090201
The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils. European journal of pharmacology 20081214
Me-talnetant and osanetant interact within overlapping but not identical binding pockets in the human tachykinin neurokinin 3 receptor transmembrane domains. Molecular pharmacology 20080601
Increased blocking activity of combined tachykinin NK1- and NK2-receptor antagonists on hyperventilation-induced bronchoconstriction in the guinea pig. Pulmonary pharmacology & therapeutics 20080101
Pharmacological analysis of components of the change in transmural potential difference evoked by distension of rat proximal small intestine in vivo. American journal of physiology. Gastrointestinal and liver physiology 20080101
Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists. European journal of pharmacology 20071222
Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans. Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20070901
Modulation of peristalsis by NK3 receptor antagonism in guinea-pig isolated ileum is revealed as intraluminal pressure is raised. Autonomic & autacoid pharmacology 20070401
Neurokinin-3 receptor-specific antagonists talnetant and osanetant show distinct mode of action in cellular Ca2+ mobilization but display similar binding kinetics and identical mechanism of binding in ligand cross-competition. Molecular pharmacology 20070301
N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists. Bioorganic & medicinal chemistry letters 20061115
Defensive and pathological functions of the gastrointestinal NK3 receptor. Vascular pharmacology 20061001
Depressed contractile responses to neurokinin A in idiopathic but not neurogenic overactive human detrusor muscle. European urology 20060301
Talnetant GlaxoSmithKline. Current opinion in investigational drugs (London, England : 2000) 20050701
A novel role for tachykinin neurokinin-3 receptors in regulation of human bronchial Ganglia neurons. American journal of respiratory and critical care medicine 20050201
Synthesis and biological evaluation of novel fluoro and iodo quinoline carboxamides as potential ligands of NK-3 receptors for in vivo imaging studies. Bioorganic & medicinal chemistry 20040815
Lithiation of functionalized fluoroquinolines: synthesis of dihalo-2-phenylquinoline-4-carboxamides and in vitro evaluation as NK-3 receptor ligands for medical imaging studies. The Journal of organic chemistry 20040402
Investigation of neurokinin-2 and -3 receptors in the human and pig bladder. BJU international 20031101
Endogenous neurokinins facilitate synaptic transmission in guinea pig airway parasympathetic ganglia. American journal of physiology. Regulatory, integrative and comparative physiology 20020801
Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists. Journal of medicinal chemistry 20010524
Molecular and pharmacological characterization of the murine tachykinin NK(3) receptor. European journal of pharmacology 20010216
Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonist. The Journal of pharmacology and experimental therapeutics 19970601
2-Phenyl-4-quinolinecarboxamides: a novel class of potent and selective non-peptide competitive antagonists for the human neurokinin-3 receptor. Journal of medicinal chemistry 19960607

Related Products

© 2019 Angene International Limited. All rights Reserved.